Brainstorm Cell Therapeutics In

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 10501E300 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G	10.0% Checked 5% or less	717,500	13G	5/15/2025 Event 3/31/2025
Armistice Capital, LLC	10.0%	717,500
Steven Boyd	10.0%	717,500
Armistice Capital, LLC 13G/A Amendment 1	4.99%	299,548	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Armistice Capital, LLC	4.99%	299,548
Steven Boyd	4.99%	299,548

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	5	2.32 k	$1.73 k	$0
2025 Q2	35	393 k	$264 k	$0
2025 Q1	33	1.02 M	$1.09 M	$0
2024 Q4	32	366 k	$473 k	$0
2024 Q3	4	157 k	$36.7 k	$0